PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Masala]

Your are right, I really do not care about small average changes in phase 2...Where the goal checking for safety, dosing levels and stuff like that. In phase 3 that's when efficacy is important and participants will mimick the average patient on the street.

And frankly I do not care about small averages ..Because I like the science and I support it since company is looking after Jewish and Muslim interests where pigs products are forbidden. Thus the data will have to change greatly for me to take interest. Even at 1.7 there would still be a substantial value in the company as a musilm American.